Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Hospital, National University Health System, Singapore, Singapore.
Department of Intensive Care Medicine, Woodlands Health, Singapore, Singapore.
Am J Respir Crit Care Med. 2022 Nov 1;206(9):1107-1116. doi: 10.1164/rccm.202112-2743OC.
Directly comparative data on sepsis epidemiology and sepsis bundle implementation in countries of differing national wealth remain sparse. To evaluate across countries/regions of differing income status in Asia ) the prevalence, causes, and outcomes of sepsis as a reason for ICU admission and ) sepsis bundle (antibiotic administration, blood culture, and lactate measurement) compliance and its association with hospital mortality. A prospective point prevalence study was conducted among 386 adult ICUs from 22 Asian countries/regions. Adult ICU participants admitted for sepsis on four separate days (representing the seasons of 2019) were recruited. The overall prevalence of sepsis in ICUs was 22.4% (20.9%, 24.5%, and 21.3% in low-income countries/regions [LICs]/lower middle-income countries/regions [LMICs], upper middle-income countries/regions, and high-income countries/regions [HICs], respectively; < 0.001). Patients were younger and had lower severity of illness in LICs/LMICs. Hospital mortality was 32.6% and marginally significantly higher in LICs/LMICs than HICs on multivariable generalized mixed model analysis (adjusted odds ratio, 1.84; 95% confidence interval, 1.00-3.37; = 0.049). Sepsis bundle compliance was 21.5% at 1 hour (26.0%, 22.1%, and 16.2% in LICs/LMICs, upper middle-income countries/regions, and HICs, respectively; < 0.001) and 36.6% at 3 hours (39.3%, 32.8%, and 38.5%, respectively; = 0.001). Delaying antibiotic administration beyond 3 hours was the only element independently associated with increased mortality (adjusted odds ratio, 2.53; 95% confidence interval, 2.07-3.08; < 0.001). Sepsis is a common cause of admission to Asian ICUs. Mortality remains high and is higher in LICs/LMICs after controlling for confounders. Sepsis bundle compliance remains low. Delaying antibiotic administration beyond 3 hours from diagnosis is associated with increased mortality. Clinical trial registered with www.ctri.nic.in (CTRI/2019/01/016898).
在不同国家财富水平下,关于脓毒症流行病学和脓毒症综合管理实施的直接比较数据仍然很少。本研究旨在评估亚洲不同收入国家/地区(1)因 ICU 收治入院的脓毒症发生率、病因和结局;(2)脓毒症综合管理(抗生素应用、血培养和乳酸测量)的执行情况及其与医院死亡率的相关性。对亚洲 22 个国家/地区的 386 个成人 ICU 进行了一项前瞻性时点患病率研究。在四个不同日期(代表 2019 年的四个季节),招募因脓毒症而被收入 ICU 的成年患者。结果显示,ICU 中脓毒症的总体患病率为 22.4%(低收入国家/地区[LICs]/中低收入国家/地区[LMICs]、中高收入国家/地区和高收入国家/地区[HICs]分别为 20.9%、24.5%和 21.3%;<0.001)。LICs/LMICs 地区的患者年龄较小,病情严重程度较低。多变量广义混合模型分析显示,LICs/LMICs 的医院死亡率为 32.6%,略高于 HICs(调整后比值比,1.84;95%置信区间,1.00-3.37;=0.049)。1 小时时,脓毒症综合管理执行率为 21.5%(LICs/LMICs、中高收入国家/地区和 HICs 分别为 26.0%、22.1%和 16.2%;<0.001),3 小时时为 36.6%(分别为 39.3%、32.8%和 38.5%;=0.001)。抗生素治疗延迟至 3 小时后是唯一与死亡率增加相关的因素(调整后比值比,2.53;95%置信区间,2.07-3.08;<0.001)。脓毒症是亚洲 ICU 患者入院的常见原因。死亡率仍然很高,在控制混杂因素后,LICs/LMICs 地区的死亡率更高。脓毒症综合管理执行率仍然较低。脓毒症诊断后 3 小时内开始抗生素治疗与死亡率增加相关。本临床试验已在 www.ctri.nic.in(CTRI/2019/01/016898)注册。